VANDETANIB - Biotechnica DWC

VANDETANIB (CAS 443913-73-3; IUPAC name: N-(4-bromo-2-fluorophenyl)-6-methoxy-7-[(1-methylpiperidin-4-yl)methoxy]quinazolin-4-amine) has molecular formula C22H24BrFN4O2 and a molecular weight of 475.4 g/mol. Marketed as Caprelsa, classified as an antineoplastic agent, supplied as 300mg, 100mg tablet, for oral administration, market status: prescription, by Ipr Pharms.